BioPharm Reports
BioPharm Reports is a sister company of VennBio, established in 2002. VennBio works with companies, universities, research institutes and investors operating in the healthcare, biomedical and bioscience fields. Their experienced team has long-standing relationships across the life science industry, with SMEs and start-ups, and have direct experience in establishing and growing successful companies.
previous
Title  | Date  | Price |
|---|---|---|
| Hypertension - Treatments and Prescribing Practices A Global Survey 2009 | Oct 2009 | £4,165 |
| Alzheimer's Disease: Markets, Pipeline and Opportunities 2009 | Apr 2009 | £1,855 |
| Cancer Drug Resistance 2008 | Sep 2008 | £1,675 |
| Antibiotics and Drug Resistance 2008 Drug Innovation and the Strategy to Combat - Antibiotic Resistance Mechanisms | Jan 2008 | £1,499 |
| Peripheral Neuropathy and Neuropathic Pain, 2008 Current, Pipeline And Emerging Drugs For The Treatment Of Peripheral Neuropathy And Neuropathic Pain | Jan 2008 | £1,499 |
| Cancer Stem Cells Emerging Therapeutic, Diagnostic and Market Opportunities (2008) | Jan 2008 | £1,600 |
Industry Events
Best Practice in Phase IV Clinical & Observational Research
03 Dec 09 to 04 Dec 09
Prague, Czech Republic
view summary >>
call +44 (0) 20 7060 7474
or email us
